These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25210064)

  • 21. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
    Sader HS; Farrell DJ; Castanheira M; Flamm RK; Jones RN
    J Antimicrob Chemother; 2014 Oct; 69(10):2713-22. PubMed ID: 24917579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomally Encoded
    Snesrud E; Maybank R; Kwak YI; Jones AR; Hinkle MK; McGann P
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility between two readout methods of a commercial broth microdilution assay for Pseudomonas aeruginosa isolates from patients with Cystic Fibrosis.
    Franssens BT; Fluit AC; Rentenaar RJ
    Infect Dis (Lond); 2019 Jan; 51(1):50-55. PubMed ID: 30654670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centres.
    Khan Z; Iregui A; Landman D; Quale J
    J Antimicrob Chemother; 2019 Oct; 74(10):2938-2942. PubMed ID: 31298277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of WalkAway MicroScan system colistin well when determining the susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii recent clinical isolates.
    Borrego-Jiménez J; Soria-Segarra C; Moldovan TD; Navarro-Marí JM; Gutiérrez-Fernández J
    Rev Esp Quimioter; 2020 Feb; 33(1):83-84. PubMed ID: 31895527
    [No Abstract]   [Full Text] [Related]  

  • 26. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
    Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
    Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin.
    Tan TY; Ng SY
    Clin Microbiol Infect; 2007 May; 13(5):541-4. PubMed ID: 17371537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method.
    He W; Kaniga K; Lynch AS; Flamm RK; Davies TA
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):417-9. PubMed ID: 22995366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study.
    Tato M; García-Castillo M; Bofarull AM; Cantón R;
    Int J Antimicrob Agents; 2015 Nov; 46(5):502-10. PubMed ID: 26315199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa.
    Tijet N; Boyd D; Patel SN; Mulvey MR; Melano RG
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4578-80. PubMed ID: 23817380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.
    Mitsugui CS; Tognim MC; Cardoso CL; Carrara-Marroni FE; Botelho Garcia L
    Int J Antimicrob Agents; 2011 Nov; 38(5):447-50. PubMed ID: 21872449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of
    Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B
    Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of mcr-1 Plasmids in Enterobacteriaceae Isolates From Human Specimens: Comparison With Those in Escherichia coli Isolates From Livestock in Korea.
    Yoon EJ; Hong JS; Yang JW; Lee KJ; Lee H; Jeong SH
    Ann Lab Med; 2018 Nov; 38(6):555-562. PubMed ID: 30027699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin.
    Turlej-Rogacka A; Xavier BB; Janssens L; Lammens C; Zarkotou O; Pournaras S; Goossens H; Malhotra-Kumar S
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):345-353. PubMed ID: 29177612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination testing of colistin with telavancin and daptomycin.
    Milne KE; Gould IM
    J Antimicrob Chemother; 2014 Dec; 69(12):3440-1. PubMed ID: 25077490
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae.
    Maalej SM; Meziou MR; Rhimi FM; Hammami A
    Lett Appl Microbiol; 2011 Nov; 53(5):546-51. PubMed ID: 21895730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods.
    Rantakokko-Jalava K; Elo-Lehtonen E; Meurman O
    APMIS; 2006 Jan; 114(1):43-9. PubMed ID: 16499660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Standardized disk tests for the determination of bacterial resistance ].
    von Graevenitz A; Heitz M; Lüthy R; Meyer J; Vischer W
    Schweiz Med Wochenschr; 1984 Aug; 114(31-32):1079-86. PubMed ID: 6436967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.